A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2006
11/23/2006	WO2006124820A2 Materials and methods for regulating blood flow
11/23/2006	WO2006124711A1 Composition and method for providing localized delivery of a therapeutic agent
11/23/2006	WO2006124667A2 Compositions and methods for modulating immune responses
11/23/2006	WO2006124661A1 Prognosis and treatment of breast cancer
11/23/2006	WO2006124611A1 Treatment of inflammatory bowel disease (ibd) with anti-angiogenic compounds
11/23/2006	WO2006124537A1 Compounds that regulate apoptosis
11/23/2006	WO2006124494A1 TRANSITION-STATE INHIBITORS OF PIN1, α-KETOAMIDE-CONTAINING PEPTIDOMIMETICS, AND SYNTHESES THEREOF
11/23/2006	WO2006124062A1 Method for fostering bone formation and preservation
11/23/2006	WO2006123827A1 Method for amelioration of disease condition induced by mood disorder
11/23/2006	WO2006123724A1 Novel pharmaceutical using anti-hla antibody
11/23/2006	WO2006123361A2 Microspheres containing goserelin or a pharmaceutically acceptable salt thereof
11/23/2006	WO2006123360A2 Microspheres containing octreotide acetate
11/23/2006	WO2006123354A2 Oral pharmaceutical composition
11/23/2006	WO2006123207A2 A kit for inhibiting gastric acid secretion having an adjustable amount of ph regulating agent
11/23/2006	WO2006123122A2 Psk- i and its modulators for the treatment/diagnosis of cancer
11/23/2006	WO2006122981A1 Use of glp-2 for the treatment of ischemia-reperfusion injury
11/23/2006	WO2006122819A1 Use of inhibitors of the renin-angiotensin system for the treatment of lung injuries
11/23/2006	WO2006122792A1 Peptides capable of modulating the function of tirc7
11/23/2006	WO2006122542A2 Non-viral vector system for transporting nucleic acid into the lungs
11/23/2006	WO2006122512A1 Fusion proteins comprising protein transduction domain, auxiliary protein and bioactive protein, their production and uses
11/23/2006	WO2006122447A1 Medicament for treating drugs abuse comprising peroxidase and its use
11/23/2006	WO2006122431A1 Triazine compounds and compositions thereof for the treatment of cancers
11/23/2006	WO2006122404A1 Trappin-2 (elafin) inhibits hiv
11/23/2006	WO2006106164B1 Dermopharmaceutical or cosmetic composition comprising enkephalin-derived peptides for reducing and/or eliminating facial wrinkles
11/23/2006	WO2006102072A3 Use of a pa131 polypeptide in treatment of atherosclerosis
11/23/2006	WO2006088833A3 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
11/23/2006	WO2006086188A3 Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
11/23/2006	WO2006086107A3 Methods and compositions for minimizing accrual of inhalable insulin in the lungs
11/23/2006	WO2006083873A3 Screening and therapeutic methods for treating circadian rhythm disorders
11/23/2006	WO2006082581A3 Synthetic peptide copolymers for treatment and prevention of cardiovascular disorders
11/23/2006	WO2006077601A3 HIV-1 gp41 FUSION PEPTIDES FOR IMMUNOMODULATION
11/23/2006	WO2006063067A3 Novel tnf receptor regulatory domain
11/23/2006	WO2006052841A3 Glycolipids
11/23/2006	WO2006033888A9 A process to treat avascular necrosis (avn) with osteoinductive materials
11/23/2006	WO2006020930A3 Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
11/23/2006	WO2005115403A3 Induction of innate immunity by vitamin d3 and its analogs
11/23/2006	WO2005110473A3 Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
11/23/2006	WO2005086967A3 Therapeutic use of rm1 antigen
11/23/2006	WO2005081711A3 Monomethylvaline compounds capable of conjugation to ligands
11/23/2006	WO2005044292A3 Biomarkers of resistance to hiv-infections in humans and biological applications thereof
11/23/2006	US20060265779 Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors
11/23/2006	US20060265770 Transgenic mice containing glutamate receptor (GRIK5) gene disruptions
11/23/2006	US20060264886 Method for altering insulin pharmacokinetics
11/23/2006	US20060264615 Which induce proliferation of lymphocytes in presence of wild-type p35 polypeptide subunit of human interleukin-12; site directed mutagenesis
11/23/2006	US20060264614 Diagnosis using inexpensive and reliable reagents; stimulate immune response; can be used to determine the susceptibility of a particular individual to a treatment regimen
11/23/2006	US20060264613 Soluble CTLA4 proteins produced by recombinant DNA methods; autoimmune diseases, transplant rejection; inhibits the co-stimulatory pathway in T cell activation
11/23/2006	US20060264611 Pancreatic islet transcription factor and uses thereof
11/23/2006	US20060264610 Protein complexes of the tip60 transcriptional activator protein
11/23/2006	US20060264609 Use of heat shock proteins
11/23/2006	US20060264607 Process for preparing glycopeptide phosphonate derivatives
11/23/2006	US20060264606 Processes for making acylated insulin
11/23/2006	US20060264605 Polypeptides having anti-HIV activity and compositions comprising same
11/23/2006	US20060264604 Anti-HBs monoclonal antibody
11/23/2006	US20060264603 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide
11/23/2006	US20060264395 Modulation of apolipoprotein c-III expression
11/23/2006	US20060264394 Livin-specific sirnas for the treatment of therapy-resistant tumors
11/23/2006	US20060264392 Modulators of angiogenesis
11/23/2006	US20060264390 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
11/23/2006	US20060264389 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
11/23/2006	US20060264381 Methods of treating obsessive compulsive disorder
11/23/2006	US20060264380 Compounds and Methods for Promoting Angiogenesis
11/23/2006	US20060264379 BIR domain binding compounds
11/23/2006	US20060264378 Cxcr4 antagonist and use thereof
11/23/2006	US20060264377 Chemically modified novel erythropoietin stimulating protein compositions and methods
11/23/2006	US20060264376 intravenously administering an aqueous solution containing mannitol and an effective amount of urodilatinto to the patient continuously
11/23/2006	US20060264375 Elastin protective polyphenolics and methods of using the same
11/23/2006	US20060264374 Conus californicus neurotoxins
11/23/2006	US20060264373 Modified vitamin K-dependent polypeptides
11/23/2006	US20060264372 Process for the synchronization of ovulation for timed breeding without heat detection
11/23/2006	US20060264371 Treatment
11/23/2006	US20060264370 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith
11/23/2006	US20060264369 Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
11/23/2006	US20060264368 Methods and Devices for Contributing to the Treatment of Aneurysms
11/23/2006	US20060264367 Prevention of fibrosis following cardiac injury
11/23/2006	US20060264365 Treatment of brain tissue damage
11/23/2006	US20060264363 Inhibition of nerve cell death by inhibiting degradation of shc3, atf6 or crebl1 by htra2 and method of ameliorating neurodegenerative diseases
11/23/2006	US20060264362 Method of modulating smooth muscle cell functioning by modulating sphingosine kinase mediated signalling
11/23/2006	US20060264361 Novel lysophosphatidic acid receptor
11/23/2006	US20060264360 Anti-inflammatory and wound healing effects of lymphoid thymosin beta-4
11/23/2006	US20060264359 inducing eosinophil apoptosis; Pin1 inhibitor is juglone
11/23/2006	US20060264358 Acylated nonadepsipeptides II
11/23/2006	US20060264357 Capillary membrane stabilization and reduction of tissue injury through use of biodegradable macromolecules with antioxidants and/or other chemicals
11/23/2006	US20060264356 Increased or improved bioavailability of the active agents for oral, intracolonic, pulmonary, and other routes of administrations
11/23/2006	US20060264355 Separating material
11/23/2006	US20060264354 Cop 1 for treatment of inflammatory bowel diseases
11/23/2006	US20060264353 Prostaglandin f2alpha analogs and their use in combination with antimicrobial proteins for the treatment of glaucoma and intraocular hypertension
11/23/2006	US20060263877 Novel megakaryocytic protein tyrosine kinase 1
11/23/2006	US20060263854 Immunodiagnostic assays using reducing agents
11/23/2006	US20060263853 Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
11/23/2006	US20060263852 Asp2
11/23/2006	US20060263851 Soluble interleukin-20 receptor
11/23/2006	US20060263850 to inhibit cytokine-mediated inflammation; two polypeptide subunits, IL-20RA (formerly ZcytoR7) and IL-20RB (formerly DIRS1); one subunit fused to constant region of light chain of an immunoglobulin; the other fused to constant region of heavy chain; light and heavy chains connected via a disulfide bond
11/23/2006	US20060263849 The analogs are resistant to diaminopeptidase IV degradation and bind zinc; are active over an extended time in vivo
11/23/2006	US20060263848 Cysteine-containing peptides having antioxidant properties
11/23/2006	US20060263847 Compositions and methods for treatment of sever acute respiratory syndrome (sars)
11/23/2006	US20060263835 autoantibodies which recognize extracellular structures of G protein-coupled receptors; autoimmune diseases; Raynaud's syndrome, cardiomyopathy, myocarditis, hypertension
11/23/2006	US20060263828 Arrestin chimera comprising naturally occurring beta-arrestin-2 and naturally occurring ubiquitin moiety, where arrestin chimera has increased affinity for GPCR, and where increased affinity means that arrestin chimera remains associated with and traffics with GPCR into endosomes
11/23/2006	US20060263827 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances
11/23/2006	US20060263820 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins
11/23/2006	US20060263819 Diagnostics and therapeutics for macular degeneration-related disorders

1 ... 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 ... 3163